Fatty acids induce increased granulocyte macrophage-colony stimulating factor secretion through protein kinase C-activation in THP-1 macrophages

Lipids
Nahid BahramianUrban Olsson

Abstract

Insulin resistance and type 2 diabetes are associated with elevated circulating levels of nonesterified FA (NEFA) and lipoprotein remnants. The dyslipidemia is an important contributor to the excess arterial disease associated with insulin resistance and type 2 diabetes, but the mechanisms involved are elusive. In the present study we examined the effect of NEFA on macrophages. For this purpose, we utilized human macrophages, prepared by treating THP-1 monocytes with phorbol ester. We found that albumin-bound NEFA at physiological levels increase the secretion of granulocyte macrophage-colony stimulating factor (GM-CSF) by the THP-1 macrophages in a dose-dependent manner. The effect was registered as an increase in mRNA, and the amount of GM-CSF secreted correlated with the accumulation of TAG and DAG in the cell. The NEFA-induced rise in GM-CSF appeared to be mediated by activation of protein kinase C, probably acting on extracellular signal-regulated kinases 1 and 2 and being calcium dependent. We speculate that increased secretion of GM-CSF by resident macrophages in the intima exposed chronically to high levels of NEFA, such as those present in insulin resistance, may contribute to a proatherogenic response of arterial cells.

References

Dec 1, 1995·The Journal of Biological Chemistry·A C Newton
Nov 1, 1995·Prostaglandins, Leukotrienes, and Essential Fatty Acids·B HennigS Ramasamy
Mar 21, 1998·Current Opinion in Biotechnology·Y S Lie, C J Petropoulos
Oct 30, 1998·Cellular Signalling·W S Liu, C A Heckman
Jan 14, 1999·The New England Journal of Medicine·R Ross
Apr 21, 1999·Current Opinion in Cell Biology·T P Garrington, G L Johnson
Feb 26, 2000·Journal of Medicinal Chemistry·T M WillsonB R Henke
Jun 10, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·M CarlssonL Groop
Aug 23, 2000·Metabolism: Clinical and Experimental·B HennigM Toborek
Oct 24, 2000·Trends in Endocrinology and Metabolism : TEM·R N Bergman, M Ader
Oct 26, 2000·Current Opinion in Lipidology·M SakaiS Horiuchi
Nov 22, 2000·Current Opinion in Lipidology·A von Eckardstein, G Assmann
Feb 13, 2001·American Journal of Physiology. Endocrinology and Metabolism·E MontellA M Gómez-Foix
Jul 17, 2001·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·E W KraegenA L Thompson
Jun 5, 2002·Atherosclerosis. Supplements·Germán CamejoGöran Bondjers

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.